TR200003521T2 - Yeniden-kombine-edilen insan interferonu beta-1a (IFN-beta-1a) formülasyonu. - Google Patents
Yeniden-kombine-edilen insan interferonu beta-1a (IFN-beta-1a) formülasyonu.Info
- Publication number
- TR200003521T2 TR200003521T2 TR2000/03521T TR200003521T TR200003521T2 TR 200003521 T2 TR200003521 T2 TR 200003521T2 TR 2000/03521 T TR2000/03521 T TR 2000/03521T TR 200003521 T TR200003521 T TR 200003521T TR 200003521 T2 TR200003521 T2 TR 200003521T2
- Authority
- TR
- Turkey
- Prior art keywords
- beta
- ifn
- formulation
- human interferon
- combined human
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 108010005716 Interferon beta-1a Proteins 0.000 title 2
- 229960004461 interferon beta-1a Drugs 0.000 title 2
- 238000009472 formulation Methods 0.000 title 1
- 102000008100 Human Serum Albumin Human genes 0.000 abstract 1
- 108091006905 Human Serum Albumin Proteins 0.000 abstract 1
- 102000003996 Interferon-beta Human genes 0.000 abstract 1
- 108090000467 Interferon-beta Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960001388 interferon-beta Drugs 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Bulus, yaklasik pH 7.2 degerinde tampon, yeniden-kombine-edilen interferon-beta ve 15 mg/ml insan serum albumini içeren sivi bilesimleri ve sözü geçen bilesimlerin parenteral kullanimi için kullanma takimlarini saglamaktadir.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1998/007242 WO1999062542A1 (en) | 1998-05-29 | 1998-05-29 | Recombinant human interferon beta-1a (ifn-beta-1a) formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200003521T2 true TR200003521T2 (tr) | 2001-07-23 |
Family
ID=22266817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2000/03521T TR200003521T2 (tr) | 1998-05-29 | 1998-05-29 | Yeniden-kombine-edilen insan interferonu beta-1a (IFN-beta-1a) formülasyonu. |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1082132A1 (tr) |
| JP (1) | JP2002516874A (tr) |
| KR (1) | KR20010052454A (tr) |
| CN (1) | CN1299285A (tr) |
| AU (1) | AU8822598A (tr) |
| BR (1) | BR9815966A (tr) |
| CA (1) | CA2333063A1 (tr) |
| EA (1) | EA200001252A1 (tr) |
| EE (1) | EE200000694A (tr) |
| HU (1) | HUP0102241A2 (tr) |
| IL (1) | IL139933A0 (tr) |
| IS (1) | IS5732A (tr) |
| NO (1) | NO20006022L (tr) |
| SK (1) | SK17762000A3 (tr) |
| TR (1) | TR200003521T2 (tr) |
| WO (1) | WO1999062542A1 (tr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020025304A1 (en) * | 2000-06-16 | 2002-02-28 | Croze Edward M. | Novel interferon for the treatment of multiple sclerosis |
| DE60130145T2 (de) * | 2000-12-21 | 2008-05-15 | Resuscitation Technologies, LLC, Santa Monica | Stabile t3 zusammensetzungen und ihre anwendung |
| CN1325651C (zh) * | 2001-05-24 | 2007-07-11 | 大连金威基因技术有限公司 | 人重组乙型干扰素的高效表达及其应用 |
| CN1535724B (zh) * | 2003-04-23 | 2012-09-05 | 北京金迪克生物技术研究所 | 重组人干扰素在制备预防严重性急性呼吸道综合征的药物的用途 |
| PT2868315T (pt) * | 2007-12-04 | 2017-09-04 | Remedy Pharmaceuticals Inc | Formulações melhoradas e métodos para liofilização e liofilizados assim produzidos |
| WO2022056233A1 (en) * | 2020-09-12 | 2022-03-17 | Academia Sinica | Re-folded human serum albumin and use thereof for anti-tumor |
-
1998
- 1998-05-29 AU AU88225/98A patent/AU8822598A/en not_active Abandoned
- 1998-05-29 CN CN98814145A patent/CN1299285A/zh active Pending
- 1998-05-29 EE EEP200000694A patent/EE200000694A/xx unknown
- 1998-05-29 IL IL13993398A patent/IL139933A0/xx unknown
- 1998-05-29 EA EA200001252A patent/EA200001252A1/ru unknown
- 1998-05-29 JP JP2000551797A patent/JP2002516874A/ja not_active Withdrawn
- 1998-05-29 BR BR9815966-6A patent/BR9815966A/pt not_active IP Right Cessation
- 1998-05-29 SK SK1776-2000A patent/SK17762000A3/sk unknown
- 1998-05-29 EP EP98939859A patent/EP1082132A1/en not_active Withdrawn
- 1998-05-29 HU HU0102241A patent/HUP0102241A2/hu unknown
- 1998-05-29 KR KR1020007013481A patent/KR20010052454A/ko not_active Withdrawn
- 1998-05-29 TR TR2000/03521T patent/TR200003521T2/tr unknown
- 1998-05-29 CA CA002333063A patent/CA2333063A1/en not_active Abandoned
- 1998-05-29 WO PCT/US1998/007242 patent/WO1999062542A1/en not_active Ceased
-
2000
- 2000-11-24 IS IS5732A patent/IS5732A/is unknown
- 2000-11-28 NO NO20006022A patent/NO20006022L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EA200001252A1 (ru) | 2001-06-25 |
| CA2333063A1 (en) | 1999-12-09 |
| CN1299285A (zh) | 2001-06-13 |
| JP2002516874A (ja) | 2002-06-11 |
| BR9815966A (pt) | 2001-02-28 |
| EP1082132A1 (en) | 2001-03-14 |
| EE200000694A (et) | 2002-06-17 |
| IS5732A (is) | 2000-11-24 |
| IL139933A0 (en) | 2002-02-10 |
| WO1999062542A1 (en) | 1999-12-09 |
| HUP0102241A2 (hu) | 2001-10-28 |
| NO20006022D0 (no) | 2000-11-28 |
| AU8822598A (en) | 1999-12-20 |
| NO20006022L (no) | 2001-01-26 |
| SK17762000A3 (sk) | 2001-07-10 |
| KR20010052454A (ko) | 2001-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69931507D1 (de) | Interferon-beta fusionsproteine und deren verwendungen | |
| PE20000560A1 (es) | Uso de peg-ifn-alfa y ribavirina para el tratamiento de hepatitis c cronica | |
| MXPA02006679A (es) | Composicion farmaceutica. | |
| DE69739665D1 (de) | Isoliertes, dimerisches fibroblasten-aktivierendes protein alpha und anwendungen desselben | |
| EP0695171A1 (en) | GONADOTROPINE CONTAINING FREEZER DRIED DROPS | |
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| MX9707431A (es) | Inhibidores de la proteina cinasa c. | |
| BR0113666A (pt) | Inibidores da protease peptidomimética | |
| SG157952A1 (en) | Small molecule antagonists of bcl-2 family proteins | |
| ATE73321T1 (de) | Zusammensetzung mit verzoegerter abgabe. | |
| BR9811744A (pt) | Conjugados contendo o homeodomìnio de antenapédia | |
| EA200501699A1 (ru) | Стабилизированные жидкие композиции интерферона, не содержащие человеческий сывороточный альбумин | |
| MY122262A (en) | Lh-rh peptide analogues their uses and pharmaceutical compositions containing them | |
| TW200510528A (en) | Polypeptide inducing apoptosis | |
| DE69905170T2 (de) | Thiazolopyrimidinderivate | |
| IT1293778B1 (it) | 1,4,7,10-tetraazabiciclo(8.2.2.)tetradecan-2 one, sua preparazione e suo uso per la preparazione di tetraazamacrocicli | |
| TR199902334T2 (tr) | Psikotik bozukluklarin tedavisi veya profilaksisi için mirtazapin ve antipsikotik ajanlarin yeni terapötik kombinasyonlari. | |
| PT1149910E (pt) | Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus | |
| ES2117976T3 (es) | Preparacion de derivados n-acetil neuraminicos. | |
| SE9702680D0 (sv) | New formulation | |
| EE05213B1 (et) | Lmfotoksiin- β retseptori (LT- β-R) blokeeriva agensi kasutamine ja LT- β-R-i blokeerivat agensit ning CD40L-i blokeerivat agensit sisaldav farmatseutiline kompositsioon | |
| TR200003521T2 (tr) | Yeniden-kombine-edilen insan interferonu beta-1a (IFN-beta-1a) formülasyonu. | |
| TR200101493T2 (tr) | Eletriptan hidrobromid monohidrat | |
| TR200001724T2 (tr) | 5-HT1F Agonistleri | |
| BR9714376A (pt) | Antagonistas de somatostatina |